|
시장보고서
상품코드
2032392
내시경 역행성 담췌관 조영술(ERCP) 시장 보고서 : 제품별, 시술별, 최종 사용자별, 지역별(2026-2034년)Endoscopic Retrograde Cholangiopancreatography Market Report by Product, Procedure, End User, and Region 2026-2034 |
||||||
세계의 내시경 역행성 담췌관 조영술(ERCP) 시장 규모는 2025년에 18억 달러에 이르렀습니다. 향후 IMARC Group은 2026-2034년 CAGR 5.36%로 성장을 지속하여, 2034년까지 시장 규모가 29억 달러에 이를 것으로 예측했습니다.
내시경 역행성 담췌관 조영술(ERCP)은 간, 담낭, 담관, 췌장의 이상을 진단하고 치료하기 위한 영상진단 기술입니다. 이 기술은 엑스레이와 식도, 구강, 위를 통과하는 길고 유연하며 가벼운 내시경 튜브를 결합한 기술입니다. 이를 통해 담관 내 막힘, 결석, 감염, 종양, 췌장관의 액체 누출을 감지하는 데 도움이 됩니다. 또한, 이 검사는 개복 수술에 비해 덜 침습적이며, 췌담도 계통에 대한 보다 상세하고 정확한 정보를 제공합니다. 이에 따라 연하장애, 설사, 체중감소, 속쓰림, 혈변 등을 조사하기 위한 내시경 치료용 기기에 대한 수요가 전 세계적으로 증가하고 있습니다.
내시경 역행성 담췌관 조영술(ERCP) 시장 동향 :
세계 인구 증가와 바렛식도, 담도질환, 간질환, 크론병, 염증성 장질환, 소화성 궤양, 위식도역류질환(GERD) 등 다양한 만성 소화기(GI) 질환 및 담도질환의 유병률 증가는 시장에 긍정적인 영향을 미치는 주요 요인 중 하나입니다. 또한, 특히 노년층에서 췌장 및 간 양성종양 발생률 증가와 더불어 전 세계 암 발생률 증가가 시장을 주도하고 있습니다. 이에 따라 병원과 진단센터의 확대로 영상진단 기술에 대한 수요가 증가하면서 시장 성장을 견인하고 있습니다. 또한, 각국 정부 및 의료기관의 첨단 내시경 장비에 대한 투자 및 내시경 조사 강화가 진행되고 있는 것도 시장 성장을 견인하고 있습니다. 이와 더불어, 조기 회복과 통증 완화를 위한 최소침습 수술에 대한 소비자의 선호도 변화와 괄약근 절개기와 같은 ERCP 장비에 대한 인식이 높아지면서 시장에 긍정적인 전망을 가져오고 있습니다. 또한, 의료 인프라의 지속적인 개선과 의료 관광의 현저한 증가도 시장 성장을 가속할 것으로 예측됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 내시경 역행성 담췌관 조영술(ERCP) 시장
제6장 시장 분석 : 제품별
제7장 시장 분석 : 시술별
제8장 시장 분석 : 최종 사용자별
제9장 시장 분석 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
JHS 26.05.18The global endoscopic retrograde cholangiopancreatography market size reached USD 1.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 5.36% during 2026-2034.
Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET TRENDS:
The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett's disease, biliary, liver, Crohn's, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.
KEY MARKET SEGMENTATION:
Breakup by Product:
- Endoscope
- Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Others
- Visualization Systems
- Energy Devices
Breakup by Procedure:
- Biliary Sphincterotomy
- Biliary Stenting
- Biliary Dilatation
- Pancreatic Sphincterotomy
- Pancreatic Duct Stenting
- Pancreatic Duct Dilatation
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgery Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Endoscopic Retrograde Cholangiopancreatography Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Endoscope
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Endotherapy Devices
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Sphincterotomes
- 6.2.2.2 Lithotripter
- 6.2.2.3 Stents
- 6.2.2.4 Others
- 6.2.3 Market Forecast
- 6.3 Visualization Systems
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Energy Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Procedure
- 7.1 Biliary Sphincterotomy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Biliary Stenting
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Biliary Dilatation
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pancreatic Sphincterotomy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Pancreatic Duct Stenting
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Pancreatic Duct Dilatation
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgery Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Boston Scientific Corporation
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 CONMED Corporation
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Cook Group Incorporated
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Fujifilm Holdings Corporation
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Hobbs Medical Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Johnson & Johnson
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Medi-Globe GmbH
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Medtronic plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Olympus Corporation
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Shaili Endoscopy
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Steris Corporation
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.12 Telemed Systems Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 Boston Scientific Corporation
